Long-term reliability of Medtronic heart rhythm devices in heart patients
Tracks how long Medtronic heart devices keep working in people with arrhythmia.
Plain-language title generated from the registry record
Registry title: Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Key facts
- Where
- Hong Kong, Hong KongSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people who are about to get, or just got, a Medtronic heart rhythm device (pacing, sensing or defibrillation). It follows how long the devices keep working.
- Sex
- All sexes can join.
- Earlier treatment
- People must be due to get, or have had within the last 30 days, at least one Medtronic market-released device for pacing, sensing or defibrillation. Or they took part in a qualifying study (IDE) of such a device with complete implant and follow-up data.
Main reasons for not taking part
- People who cannot be reached for follow-up now or later
- People with exclusion criteria required by local law (EMEA only)
- People implanted at a non-participating center when implant data and current status cannot be confirmed within 30 days after implant
- People with a Medtronic device whose set enrollment limit for that product has been exceeded
Read by machine on 9 November 2026.
Where in Hong Kong
- Hong KongHospital not named in the registryTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Medtronic
- Trial code
- NCT00271180
- Record updated
- 4 November 2026
- Original description
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.Read full original descriptionShow less
Medtronic CRDM Product Performance Report
The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.
Inclusion: Subject or appropriate legal guardians provide written informed consent and/or authorization for access to and use of health information as required by an institution's IRB/MEC/REB; AND one of the following must also apply:; Subject is indicated for implant or within 30 days post-implant of at least one Medtronic market-released product used for a pacing, sensing or defibrillation application; Subjects who participated in a qualifying study (IDE) of a Medtronic market-released product with complete implant and follow-up data and subject or appropriate legal guardian authorizes release of subject study data.
Exclusion: Subjects receiving an implant of a Medtronic device at a non-participating center and the implant data and current status cannot be confirmed within 30 days after implant; Subjects who are, or will be inaccessible for follow-up; Subjects with exclusion criteria required by local law (EMEA only); Subjects implanted with a Medtronic device whose predetermined enrollment limit for that specific product has been exceeded.
Subjects who meet the following inclusion criteria and do not meet any of the following exclusion criteria are eligible for enrollment.